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Abstract
Background: In humans, copies of the Long Interspersed Nuclear Element 1 (LINE-1) retrotransposon comprise
21% of the reference genome, and have been shown to modulate expression and produce novel splice isoforms
of transcripts from genes that span or neighbor the LINE-1 insertion site.
Results: In this work, newly released pilot data from the 1000 Genomes Project is analyzed to detect previously
unreported full length insertions of the retrotransposon LINE-1. By direct analysis of the sequence data, we have
identified 22 previously unreported LINE-1 insertion sites within the sequence data reported for a mother/father/
daughter trio.
Conclusions: It is demonstrated here that next generation sequencing data, as well as emerging high quality
datasets from individual genome projects allow us to assess the amount of heterogeneity with respect to the LINE-
1 retrotransposon amongst humans, and provide us with a wealth of testable hypotheses as to the impact that
this diversity may have on the health of individuals and populations.
Background
The Long Interspersed Nuclear Element 1 (LINE-1) ret-
rotransposon is a repeat sequence that comprises
roughly 21% of the human genome [1]. As many as 100
full length copies of the LINE-1 element have been
demonstrated to be active and capable of retrotransposi-
tion within the human genome [2]. These genetic ele-
ments provide a dynamic and pervasive mechanism by
which the genome may mutate, and through which it
may evolve [1,3]. Several LINE-1 elements have been
implicated as disease causing or mediating agents [4].
Since LINE-1 is retrotranspositionally active it is
expected that analyses of emerging personal genome
data would reveal a great many insertions and deletions
relative to the published reference sequence for the
human genome. Projects such as the 1000 genomes
project provide an unprecedented opportunity to analyze
the complete genomes of large populations in order to
assess the amount of diversity present among them. In
this work, pilot trace data from the 1000 genomes pro-
ject (http://www.1000genomes.org) is analyzed for
genetic diversity in terms of sequence elements that sug-
gest full length, and therefore potentially active inser-
tions of the LINE-1 retrotransposon relative to the
published reference sequence for the human genome.
Twenty-two of these elements have been identified in
this work. Next generation sequencing technology is
emerging as an affordable tool that will allow clinicians
and researchers to develop a comprehensive picture of
an individual’s genetic composition. The results of this
study demonstrate clearly that as the medical field
moves toward personalizing medical treatment, it will be
important to assay an individual’s genome for LINE-1
elements unique to them that may prove disruptive to
normal cellular function.
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of replicating themselves throughout the genome. The
process of retrotransposition results in the de-novo
insertion of either a full length, or truncated copy of the
retrotransposing element into an individual’sg e n o m i c
DNA. Previously unreported insertions can be found
when analyzing a diverse human population [5], and
have even been detected when comparing human gen-
ome assemblies from different sources [6]. In a study
similar to the work presented here, it is reported that
the majority of intermediate length structural variation
that distinguishes inbred mouse strains from one
another was caused by “…endogenous retrotransposi-
tion, predominantly by L1 retrotransposons” [7].
The full length LINE-1 retrotransposon is approxi-
mately 6000 nucleotides in length, and is characterized
by two open reading frames, referred to in the literature
as ORF1 and ORF2, which code for the proteins neces-
sary to support the retrotransposition process [8]. Speci-
fic LINE-1 alleles have been identified as a disease
causing or mediating agents (ref [4] and references
therein). Although the function of the majority of the
genome is not yet understood, it is clear that a retrotran-
sposition event could introduce damage by inserting
LINE-1 into an exon, or untranslated regions of the gen-
ome that may have regulatory function, and as a result
modify a transcript, or modulate expression [9]. Also, it
has been described [9-12] that LINE-1 contains the
necessary functional elements, namely a 5′ UTR promo-
ter that is capable of promoting transcription in either
direction, that would drive not only the expression of
LINE-1, but perhaps also of the genes that neighbor it.
Although no specific evidence has been reported, this
makes plausible the notion of ectopic expression of genes
to which the LINE-1 insertion is proximal, or intragenic
[9]. Furthermore, it has been reported that LINE-1
expression is increased dramatically under exposure to
UV radiation [13], and under insult of the common
environmental pollutant benzo(a)pyrene [14,15].
Increased expression of this element either endogenously,
or due to environmental insult would not only serve to
increase its ability to effect the expression of neighboring
genes, but would also increase the likelihood of retrotran-
sposition and, therefore possibility of somatic mutation.
[3] Since this mobile element has been tied to disease,
and clearly has the potential to wreak havoc with each
retrotransposition event (the rate of which has estimates
of between 1 in 30 and 1 in 500 in human germ cells [2]),
it is clear that this is an element that must be accounted
for when assessing an individual’s genetic composition.
Results
In this study, only putative full-length LINE-1 insertion
events were investigated. The reason for this is twofold.
First, the full-length LINE-1 insertions are likely to have
the greatest functional impact on their region of the
genome. Secondly, the vast majority of the LINE-1s that
are found in the genome are truncated and are missing
the 5′ end. Identifying those reads that contained an
insertion site for a truncated copy of LINE-1 is a more
complex challenge as it is not clear that a read that con-
tains LINE-1 sequence will also contain an insertion site,
or will otherwise be comprised completely of LINE-1
sequence. By limiting the search to the 5′ end of the
LINE-1 transcript, it was guaranteed that each read that
contained this sequence segment would also contain the
insertion site. It should be noted that LINE-1 deletion
events were not considered in this phase of the project.
The search of trace data for the NA12878 sample
revealed 22 insertions relative to build 36.3 of the human
genome (Table 1). The trace data for the parents,
NA12891 (Father) and NA12892(Mother) was searched
using the insertion site flanking sequence 5′ to the LINE-
1 element to determine if the insertion was inherited or if
it occurred de-novo. No examples of de-novo full length
insertions in the NA12878 sample were detected. Several
of the identified insertions appeared to be homozygous,
that is, all reads identified which contained the flanking
5′ sequence also contain the LINE-1 insert, but these
findings require additional testing to substantiate them.
Of the 22 insertion sites identified for NA12878, 10 of
the inserts are intragenic, and of those, 3 were located
on the sense strand relative to the gene in which they
were inserted. We chose to validate the 3 sense
intragenic insertions (PRKCA, GLCCI1, and TRDN in
Table 1) via allele specific PCR, as well as an intergenic
insertion (position 21243489 on chromosome 5) for
which there was no strong evidence within the sequence
data to conclude that the insertion was inherited. LINE1
+ and LINE1- alleles identified in the sequencing data
were confirmed via allele specific PCR using methods
described in the methods section, similar to those
reported in Bennett et al. [5] The gel images are shown
in Figure 1. The PCR products produced confirmed the
results derived from the sequencing data, and confirmed
that the insertion at position 21243489 on chromosome
5 for the daughter was inherited.
Finally, it should be noted that the decision to utilize
the exact string match criteria described in the methods
section will prove restrictive with respect to the compre-
hensive identification of all novel LINE-1 insertions in
these datasets, both in terms of full length inserts that
v a r y ,e v e nb yas i n g l eb a s e ,f r o mt h es e a r c hs u b s e -
quence, as well as for even modestly truncated LINE-1
inserts. The manifold of subsequences that would have
been necessary for a comprehensive search using this
exact string match criteria would have been very large.
This is a shortcoming of the search strategy that will
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nologies improve and read lengths of 70 to 500 nucleo-
tides become available from the 1000 Genomes project
and other whole genome sequencing efforts. At that
point, more comprehensive search strategies as
described in the methods section that are tolerant of
both sequence variation, and LINE-1 truncation will be
possible since the longer reads that span LINE-1 splice
s i t e sw i l lb em o r el i k e l yt oc o n t a i ne n o u g hL I N E - 1
sequence to confidently identify high fidelity matches to
LINE-1, as well as sufficient flanking sequence to
uniquely place the insert site in the genome. Specifically,
we will be able to employ robust search and alignment
tools such as BLAST [16,17] and BLAT [18] instead of
the exact string match. However, even using the exact
string match criteria we successfully identified 22 puta-
tive full length insertions that do not appear in the
r e f e r e n c eg e n o m ew h i c hi ss u g g e s t i v eo fh u n d r e d so f
insertions that will be identifiable when using more
comprehensive search strategies.
Discussion
As the price of sequencing is driven down by next
generation technologies, the reality of personal
genomes for use in research, the clinic, and personal
edification is destined to become a reality. In 2007 and
2008 the results of the deep sequencing of Craig Ven-
ter [19], and James Watson [20] were reported respec-
tively. The former was produced using Sanger
technology, and the latter, next generation technology.
Since then, larger scale sequencing projects have
begun such as the 1000 genomes project, the personal
genome project (http://www.personalgenomes.org/),
and additional individual projects are being undertaken
[21,22]. A finding common in each of the published
individual sequencing efforts is the discovery of hun-
dreds of thousands of previously unreported poly-
morphisms. Conservative estimates from the data
produced in the Venter and Watson studies place the
number of new SNPs in excess of 600,000, and the
number of new IN/DELs in excess of 22,000 [20].
It has previously been reported that there are in
excess of 7000 full-length copies of LINE-1 in the refer-
ence genome sequence [23]. In this work, 22 insertions
are being reported in an individual that are consistent
with full-length LINE-1 elements (i.e. putative) known
to be retrotranspositionally active that have not been
identified previously. However, no de-novo insertions of
Table 1 Description of the LINE-1 insertion sites identified in this study






LINE-1 Orientation Gene Locus Entrez ID Gene orientation
Chr_2 144021434 +/- +/- N - ARHGAP15 55843 +
Chr_3 38601086 +/- +/- +/- + SCN5A 6331 -
Chr_3 82073683 +/- Y N -
Chr_3 125073416 Y +/- Y + MYLK 4638 -
Chr_3 187854832 +/- N Y +
Chr_4 132401098 +/- +/- +/- -
Chr_4 147444745 +/- N Y + SLC10A7 84068 -
Chr_5 (*) 21243489 Y +/- +/- +
Chr_5 89486537 Y Y Y +
Chr_6 102952779 +/- +/- N -
Chr_6 (*) 123895635 +/- +/- N - TRDN 10345 -
Chr_7 (*) 7985552 +/- N +/- + GLCCI1 113263 +
Chr_7 53619996 +/- Y ?/? -
Chr_10 124445220 Y +/- Y +
Chr_11 109883089 Y N +/- -
Chr_12 125368882 +/- N +/- -
Chr_13 60360333 Y Y +/- -
Chr_14 51737509 Y Y Y -
Chr_15 31819131 Y +/- +/- - RYR3 6263 +
Chr_15 54038444 +/- N +/- + NEDD4 4734 -
Chr_17 (*) 62067756 +/- +/- N + PRKCA 5578 +
Chr_18 12481262 +/- N +/- + SPIRE1 56907 -
Legend: Position and genotype for the twenty two LINE-1 putative full length insertions identified in this work. The splice site position is the position of the base
nearest the 5′ most base of the LINE-1 insertion in the human genome assembly build 36.3. A ‘Y’ genotype indicates that all reads found for that individual at
that position contained the LINE-1 insert. An ‘N’ genotype indicates that no reads found for that individual at that position contained the LINE-1 insert. A ‘+/-‘
genotype indicates the individual was heterozygous at that position, and ‘?/?’ indicates that no reads could be found for that individual at that position. The L1
orientation of + and – indicate sense and antisense insertion respectively with respect to the assembly. Those rows marked with an (*) were verified by PCR.
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ple. The insertions detected here were identified using
an exact match to a 14 nucleotide sequence for reasons
that are specific to the short reads available at the time
of analysis (see methods). As longer reads become avail-
able, more flexible alignment searches will be possible,
and the numbers of detectable insertions will, almost
certainly, increase significantly.
A limitation of current next generation sequencing
technology is the ability to fully characterize these inser-
tions. Current sequence lengths are on the order of sev-
eral hundred nucleotides, and the full-length LINE-1
element containing both ORF1 and ORF2 is greater
than 6000 nucleotides in length. A full characterization
would include the assignment of the LINE-1 to one of
the many evolutionary families known to exist within
humans [24]. Full-length sequencing of the entire insert
is necessary not only to assign the LINE-1 to a family,
but also in order to be able to assess the integrity of the
LINE-1 open reading frames, and the internal promoter
elements. Mutations in these regions will significantly
affect the activity of the LINE-1 element, and thus, its
impact on cellular function.
Several of the LINE-1 elements identified here are
intragenic, may be full length, intact elements, and thus,
may be of clinical significance. It is critical that as next
generation data is analyzed, care is taken not to obscure
the data necessary to perform analyses such as these. It
is common to mask/trim known repeats prior to map-
ping a trace. If masked, the high quality traces selected
Figure 1 Allele specific confirmation of genotypes. Gel images of four validation runs using allele specific PCR. Each lane is labeled with a
sample identifier D=NA12878(daughter), F=NA12891(father), M=NA12892(mother), and C=Control. For each locus, the samples were run against
two pairs of primers, one that would amplify DNA that contained a LINE1 insertion (L1+), and one that would amplify DNA that did not (L1-).
The four insertion sites chosen for validation were a) the intergenic region on chromosome 5 located at position 21243489 on human genome
build 36.3, and those insertions within the loci for b)TRDN, c) GLCCI1, and d) PRKCA. See the Methods section for more details regarding the
primer sequences and PCR conditions.
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of these insertions would be impossible in the mapping
process. However, if the repeat region is annotated for
the read (even if it is masked), the fact that it aligns to a
region with no currently known repeat region would
signal the presence of an insertion. Such considerations
are important, as it is currently not clear how scientists
will utilize this information, whether at the level of the
assembly, or if the called reads will be the basis of
further analysis.
T h ef i n d i n g so ft h i ss t u d ya n dt h o s ep u b l i s h e dp r e -
viously make clear that as more individual genomes are
sequenced there will be vast increases in the number of
reported polymorphisms. The technology now exists for
scientists and clinicians to perform a comprehensive
assay of genetic makeup of individuals. The next step is
to assess the clinical relevance of these individual differ-
ences, as evidenced by diseases/disorders of altered gene
expression, genomic instability or genetic toxicity. Of
general interest are mutations in genes encoding for
proteins involved in basal transcriptional control and
responsible for reordering regions of broad local enrich-
ment and control of chromatin structure (BLOCS). Epi-
genetic silencing of LINE-1 by way of DNA methylation
of CpG loci within the LINE-1 promoter [25] via DNA
methyltransferases as well as the involvement of E2F/
Rb/HDAC complexes in the regulation of chromatin
status [26] allow for the possibility of new treatment of
LINE-1-mediated human diseases, once they are identi-
fied. Epigenetic drugs may help in disease treatment via
modulation of the epigenetic status of BLOCS where
LINE-1 sequences act as centers for epigenetic nuclea-
tion and heterochromatin formation. For example, DNA
demethylating agents such ast h ea n t i n e o p l a s i c5 - A z a C ,
and histone deacetylase inhibitors alone or in combina-
tion could restore gene expression levels of eukaryotic
genes silenced as a result of LINE-1 insertion and LINE-
1-mediated epigenetic silencing.
Conclusion
LINE-1 is an active retrotransposon that has been
demonstrated to affect clinical phenotype [4,27]. In this
study, twenty two previously unreported insertion sites
have been identified for an individual that are consistent
with full length insertions of the LINE-1 retrotranspo-
son, 10 of them intragenic. As we move toward the
paradigm of personalized medicine, it is clear that more
work is necessary to fully catalogue the diversity with
respect to this element within the human population.
This will allow us to assess the allele frequency of all
existing LINE-1s, and begin to classify them with
respect to clinical relevance. This understanding will put
us in a much better position to evaluate the impact of
de novo insertions as they are discovered since this is an
element that should be accounted for when performing
genetic tests for disease causing mutations.
Methods
Sequence search
Pilot sequence data was downloaded from the 1000 gen-
omes ftp site located at NCBI [28]. The genome used
for all alignments and comparisons was the reference
assembly from NCBI Build 36.3, specifically, those
sequence files with the “hs_ref_” prefix in the directory
/genomes/H_sapiens/ARCHIVE/BUILD.36.3/Assemble-
d_chromosomes of the NCBI ftp site. The samples
searched were a HapMap family trio daughter
(NA12878), father (NA12891), and mother (NA12892)
belonging to the CEPH/Utah pedigree with the family id
of 1463 in the Coriell repository. Previously unreported
LINE-1 insertion sites were detected via an exact string
search within each NA12878 trace for the pattern
GGGGAGGAGCCAAG and its reverse complement
taken from the Human LINE-1 (L1.4) entry in GenBank
(Version L19092.1; GI:307102 nucleotide positions 2-
15). This sequence element is conserved in the 5′ end of
the 5′ U T Ro fO R F 1i nm a n yo ft h es e q u e n c e si nt h e
active L1Ta-1 family (accessions taken from reference
[24]). The short sequence was chosen because much of
t h ep i l o td a t aa c c e s s i b l ea tt h et i m eo ft h i ss t u d yw a s
produced on platforms that produced shorter reads (48
nucleotides or shorter). In order to locate the insertion
site within the genome, it was necessary to have suffi-
cient high quality non-LINE-1 sequence within the read
that flanked the insert (~25 nucleotides in length). As
such, the 14 nucleotide search sequence often resulted
in hits with enough flanking sequence, even in the
shorter reads, to map the insertion site to the genome
and generate additional flanking sequence from the gen-
ome consensus to search for other sequences that corro-
borated the insertion, or provided evidence that the
insertion was heterozygous.
Those reads from the NA12878 individual that con-
tained a putative LINE-1 insertion that did not appear
in the reference assembly build 36.3 were stored. This
search was performed with BLAT [18]. A total of 22
such locations were found for this sample. Regions of at
least twenty-five bases in length flanking the 5′ end of
these LINE-1 insertions were stored and used to search
the sequence data for other traces in all samples span-
ning the insertion site. If the flanking region was either
shorter than 25bp or was not unique in the genome, it
was discarded. A blastable database containing the fil-
tered set of 22 sequences was created using formatdb.
Fastq files for the individual genome projects NA12878,
NA12891, and NA12892 were distributed using the
Torq scheduler’s qsub command. Each of the sequences
were converted to fasta format on the fly, piped
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NCBI’s blastn v2.2.19 with the parameters –m8–W2 2
to find only regions highly similar to the flanking
regions. Those regions returning blast hits according to
these parameters were further mapped to each of the 24
chromosomes of the human genome individually using
BLAT [18]. The BLAT results were sorted according to
their chromosomal location. Hits overlapping the same
region were grouped together to produce a sequence
alignment. The alignments for all loci can be found in
the additional file 1. The location of the 5′ end of the
LINE-1 element was noted by the presence of either
GGGGAGG or its reverse complement CCTCCCC and
marked by a ‘*’. These alignments were further visually
inspected to test for the presence of homozygosity or
heterozygosity of the LINE-1 element within each of the
datasets for the three individuals. The process is illu-
strated in Figure 2. It must be noted that the dataset at
the time of analysis did not provide deep coverage for
all insertion sites. As such, these inspections can only
offer insights with respect to hetero- or homozygosity
that require further testing. In some cases in the analysis
of the parent data, we were not able to identify traces
with flanking data that had the 5′ LINE-1 signature. In
many of those reads, a poly-A track was found that was
not consistent with the corresponding locus on the gen-
ome assembly. This poly-A track was taken to be suffi-
cient evidence of the 3′ poly-A tail of LINE-1, and the
sample would have been designated as having a LINE-1
genotype. This poly-A tail condition was used only for
the parents. In all cases for the daughter, the 5′ end of
LINE-1 was identified in at least one read.
In a few cases, early indications suggested that inser-
tions found in the NA12878 (daughter) were not inher-
ited from either parent and appeared to be de novo. For
these insertions, we performed ad hoc string searches
that included 10 to 15 bases of unique flanking
sequence as well as the first 7 bases sequence from the
5′ end of the LINE-1 insert. As such, several sequences
can be found in the alignments in additional file 1 that
d on o tp a s st h e2 5b a s e so ff l a n k i n gs e q u e n c er e q u i r e -
ment described above.
Justification for choice of sequence search method
The aim of this work is the identification of full-length
LINE-1 insertions that do not appear in the human
Figure 2 Diagram of insert search process. A diagram describing the sequence search process by which putative full length LINE-1 insertion
sites were identified.
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sequence reads amongst the pilot data that contained
the LINE-1 insertion site. We define reads that contain
the insertion site as those that include the 5′ end of the
LINE-1 insert, as well as enough sequence flanking the
insertion site that it is possible to place the insertion
site uniquely in the genome. For this, we needed 25
nucleotides or more of unique, non-LINE-1 sequence
within the read. The best choice for a sequence search
s t r a t e g yi nc a s e ss u c ha st h i si so n et h a te m p l o y sa n
alignment search tool such as BLAST [16,17] or BLAT
[18] that will identify high scoring pairs (HSPs) of align-
ments between subsequences of the full length LINE-1
and those reads that contain LINE-1 sequence. With
sufficiently long reads (~70 nucleotides or longer), this
strategy would make it possible to confidently identify
those reads that contain high fidelity matches with any
LINE-1 subsequence. Additionally, it would be tolerant
of gaps and mismatches, and would make it possible to
identify evidence of truncated LINE-1 insertions. How-
ever due to the shorter sequences, in many instances 48
or fewer nucleotides, the HSPs that would have been
returned would have been difficult to interpret. Those
that contained shorter LINE-1 alignments (20 or fewer
nucleotides), and hence more unique non-LINE-1
sequence, were difficult to evaluate in terms of actual
LINE-1 composition. For those that contained longer
LINE-1 sequences it was easier to assess their LINE-1
composition, but difficult or impossible to place in the
genome by virtue of the fact that they had less unique
non-LINE-1 sequence. Also, polymorphisms, either sin-
gle nucleotide, or insertion/deletion, combined with low
quality sequence may truncate the HSP, falsely suggest-
ing a truncated LINE-1insertion.
As described in the results section, the search for
putative full length insertions is advantageous for two
reasons. First, since the subsequence is the 5′ most end
of the LINE-1 transcript, it is guaranteed that any read
containing the subsequence will also contain the insert
site. Other subsequences taken from the LINE-1 tran-
script presented a more difficult analysis scenario.
Secondly the full length insertions are likely to have the
greatest regulatory impact. The choice of a short subse-
quence was made to increase the likelihood that we
would have sufficient non-LINE-1 sequence in any read
identified to uniquely place the sequence in the genome.
These issues will be mitigated when longer sequence
data becomes available, and a more comprehensive
search will be possible that identifies both truncated,
and polymorphic insertions with confidence.
PCR analysis
PCR was performed to confirm the presence of LINE1+
and LINE1- in four loci, chromosome 5, position
21243489, TRDN (entrez_id=10345), GLCCI1 (entre-
z_id= 113263), and PRKCA (entrez id = 5578). Primer3
[29] was used to design the primers for these reactions
that flanked each of the four insertion sites. The
sequence for L19092.1 was used as the template for the
LINE-1 insertion, and a 3′ oligo was designed
TGAACCCGGTACCTCAGATG, that when used with
the 5′ oligo would produce a PCR product if the LINE-1
element was present in the locus as suggested by the
sequence data. The full list of primer pairs used is shown
in Table 2. Standard PCR conditions were used with an
annealing temperature of 61.3°C for 35 amplification
cycles. The Fisher Bioreagents exACTene DNA Ladders
mid range plus DNA ladder was used to assess the length
Table 2 Primers used for allele specific PCR
Locus/Allele 5’ Oligo 3’ Oligo PCR Product Size(nt)
Chr5:21243489_L1+ ttgcctaagcttcccataca TGAACCCGGTACCTCAGATG 539
Chr5:21243489_L1- ttgcctaagcttcccataca tgatccatgtcaataatgaggtc 677
TRDN_L1+ tttcatgccatctctatattccaa TGAACCCGGTACCTCAGATG 477
TRDN_L1- tttcatgccatctctatattccaa aaaaacaggcctgagattgc 690
GLCCI1_L1+ tcctcatacaaacttgtgaagtgat TGAACCCGGTACCTCAGATG 666
GLCCI1_L1- tcctcatacaaacttgtgaagtgat ttcaagcttcatctaatgaaagaaaa 682
PRKCA_L1+ tgtgcaaatttcaccccata TGAACCCGGTACCTCAGATG 527
PRKCA_L1- tgtgcaaatttcaccccata ccatagagcagtgacccaca 622
Legend: Primers used for the allele specific PCR verification of the next generation sequence data analysis. The same right primer was used in all L1+ PCR
reactions. This primer spans bases 90 to 109 of the LINE-1 transcript with accession L19092.
Table 3 Insertions identified by sequence search of
whole genome shotgun sequence data









Legend: The splice site position is the position of the base nearest the 5′ most
base of the LINE-1 insertion in the human genome assembly build 36.3.
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were obtained from the Coriell Institute.
Addendum
A paper recently published by Ewing and Kazazian [30]
subsequent to the original presentation of this work
introduced next generation sequencing for the identifi-
cation of LINE-1 inserts within individual genomes.
Their analysis included the same three Caucasian sam-
ples analyzed in this work along with samples from 22
other individuals from ethnic backgrounds that
included, Caucasian, Yoruban and Japanese. Of the 22
putative full length inserts identified here, 14 of them
were confirmed by Ewing and Kazazian. The eight addi-
tional inserts identified he r e( T a b l e3 )e m p h a s i z et h e
need for complementary approaches to the identification
of comprehensive LINE-1 insertion profiles in humans.
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